ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Universe Pharmaceuticals INC (NASDAQ:UPC), a pharmaceutical company trading at $0.19 per share, announced today a change in its proposed share consolidation ratio. The company's stock has experienced ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

Avadel Pharmaceuticals' stock is undervalued due to peak sales potential, along with the possibility of a buyout. Click here ...

DUBAI: Dubai’s Arab Health medical expo could be the medicine to the Pakistani pharmaceutical and surgical industry’s market ...

Last year, the state committee canceled over $2 million in tax incentives for tech firm Cognizant Technology Solutions, which ...

However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

In California, technology, retail and pharmaceutical companies appear to be taking on the bulk of the layoffs as employers ...

A pair of Chinese manufacturers whose active pharmaceutical ingredients (API) were previously shipped to the U.S. | The FDA ...

Shares of AstraZeneca Pharma India Ltd closed at ₹7,450 on the BSE, down 1.29% ahead of the earnings announcement.

Stock analysts at Leerink Partnrs upped their Q1 2025 earnings per share (EPS) estimates for Regeneron Pharmaceuticals in a ...

We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at ...